Skip to main content
Clinical Trials/NCT05717309
NCT05717309
Completed
Not Applicable

Trajectories of Chronic Multimorbidity Patterns in Patients >65 Years Old. MTOP

Corporacion Parc Tauli1 site in 1 country3,988 target enrollmentFebruary 10, 2022
ConditionsChronic Disease

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Disease
Sponsor
Corporacion Parc Tauli
Enrollment
3988
Locations
1
Primary Endpoint
Chronic multimorbidity patterns - Time Frame 2
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Following the MRisk-COVID project, MTOP (Multimorbidity Trajectories in Older Patients) study was developed. It is a retrospective observational study using Real World Data that aims to identify patterns of chronic multimorbidity in patients aged ≥65 years and their evolution and trajectories in the previous 10 years. The secondary objective is to identify the relationship between the trajectories of multimorbidity patterns in the previous 10 years and the severity of the infection by COVID-19.

Detailed Description

Multimorbidity is associated with negative results and presents difficulties in clinical management. Recently, new methodologies are emerging based on the hypothesis that chronic conditions are associated in a non-random way forming multimorbidity patterns. However, there are few studies that study the temporal evolution and trajectories of these multimorbidity patterns, which could be associated with different prognoses and could allow better forecasting and planning. The primary objective of this analysis is to identify patterns of chronic multimorbidity in patients aged ≥65 years and their evolution and trajectories in the previous 10 years, using part of the MRisk-COVID project data. As a secondary objective, the investigators want to identify the relationship between the trajectories of multimorbidity patterns in the previous 10 years and the severity of the COVID-19 infection. This retrospective observational study has a historical cohort of 3958 patients ≥65 years of age suspected and confirmed of COVID-19 infection from February 1 to June 15, 2020 in the reference area of Parc Taulí University Hospital. The available data (real-world data) are socio-demographic and diagnostic variables provided by the Data Analytics Program for Research and Innovation in Health (PADRIS), which include sex, age and primary care diagnoses. To identify patterns of multimorbidity, the Clinical Classification Software, Chronic Condition Indicator, multiple correspondence analysis and cluster analysis using the fuzzy c-means algorithm will be used. Then, a clinical consensus process (Delphi-like) will be made of the clusters obtained. To identify the most probable trajectories along the three time points, each patient will be assigned to the cluster with the highest probability of membership. Descriptive and bivariate statistics will be performed.

Registry
clinicaltrials.gov
Start Date
February 10, 2022
End Date
July 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Corporacion Parc Tauli
Responsible Party
Principal Investigator
Principal Investigator

Marina Lleal Custey

Principal Investigator

Corporacion Parc Tauli

Eligibility Criteria

Inclusion Criteria

  • Positive results of COVID-19 laboratory tests
  • COVID-19 related clinical profile verified by healthcare professionals

Exclusion Criteria

  • Males \>90 years (re-identification risk)

Outcomes

Primary Outcomes

Chronic multimorbidity patterns - Time Frame 2

Time Frame: 5 years before (2015)

Obtained using fuzzy c-means cluster analysis

Chronic multimorbidity patterns - Time Frame 3

Time Frame: 10 years before (2010)

Obtained using fuzzy c-means cluster analysis

Chronic multimorbidity patterns - Time Frame 1

Time Frame: Baseline (2020)

Obtained using fuzzy c-means cluster analysis

Trajectories of chronic multimorbidity patterns

Time Frame: Change over 10 years

Obtained by assigning the highest probable cluster at each time point

Secondary Outcomes

  • Severe COVID-19 infection(From 27-February-2020 to 15-June-2020)

Study Sites (1)

Loading locations...

Similar Trials